UroGen Pharma URGN Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
Based on the most recent quarter.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's quick ratio?
- UroGen Pharma (URGN) reported quick ratio of 4.3× in Q1 2026.
- How has UroGen Pharma's quick ratio changed year-over-year?
- UroGen Pharma's quick ratio decreased by 21.8% year-over-year, from 5.5× to 4.3×.
- What is the long-term trend for UroGen Pharma's quick ratio?
- Over 5 years (2020 to 2025), UroGen Pharma's quick ratio has grown at a -7.2% compound annual growth rate (CAGR), from 5.3× to 3.7×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.